Autres langues Sun Pharmaceutical Industries Ltd.

Actions

SUNPHARMA

INE044A01036

Produits pharmaceutiques

Temps Différé NSE India S.E. 11:12:04 08/10/2026			Varia. 5j.	Varia. 1 janv.
1 753,60 ^INR	-1,54%		-3,47%	+1,97%

07/10	Sun Pharmaceuticals envisage de lever 1,55 milliard de dollars via des obligations	RE
07/10	Sun Pharma crée une chaire de dermatologie au Mount Sinai de New York	MT

Autres langues

07/10	India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures
07/10	Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
07/10	Sun Pharma Establishes Dermatology Professorship at Mount Sinai in New York
01/10	Sun Pharmaceutical Industries Limited Reports Two-Year LEQSELVI Deuruxolitinib Data In Severe Alopecia Areata Showing Sustained Efficacy And Safety At EADV Congress
30/09	Pharmazz, Inc. Receives U.S. FDA IND Clearance To Initiate Phase 3 Clinical Trial Of Sovateltide In Traumatic Brain Injury
30/09	Sun Pharma Plans $1.04 Billion via Rupee Bonds to Refinance Organon Bridge Loan
30/09	Mayne Pharma Group Settles Patent Litigation With Sun Pharmaceutical Industries
29/09	India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
28/09	LIB Therapeutics Inc. And Sun Pharmaceutical Industries Limited Announce Global Licensing, Commercialization And Manufacturing Agreement For Lerodalcibep, A Novel PCSK9 Inhibitor, Ex-US And China
28/09	Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
28/09	Sun Pharma Gets Rights to Commercialize Cholesterol Drug Outside US, China
24/09	Sun Pharmaceutical Industries Limited Launches Taro-Methylphenidate ER In Ontario And Quebec
24/09	Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
09/09	Sun Pharma Sets Up Global Treasury Center in India's GIFT City
09/09	Sun Pharma Assigned Baa1, BBB+ Ratings by Moody's, S&P
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
31/08	Trump announces new round of drug-pricing deals
05/08	CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities
31/07	Sun Pharmaceutical's Consolidated Net Profit Grows in Fiscal Q1
31/07	Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
31/07	Sun Pharma's quarterly profit jumps on strength in specialty medicines
30/07	Sun Pharma Gets Brazil Approval for Semaglutide Injection
29/07	Sun Pharmaceutical Industries Limited Receives Approval to Manufacture and Market Semaglutide in Brazil
22/07	Trump will Generika-Produktion mit massiven Zöllen in die USA zwingen
21/07	South Africa regulator reviews 12 generic semaglutide applications